Literature DB >> 30359617

Shared Decision-making and Lung Cancer Screening: Let's Get the Conversation Started.

Nichole T Tanner1, Gerard A Silvestri2.   

Abstract

Screening with low-dose CT scan has been shown to reduce mortality from lung cancer in those at risk based on age and smoking history. While lung cancer screening (LCS) is recommended by the United States Preventative Services Task Force and many professional societies, it has been recognized that the decision to be screened is complex due to a close balance of risk and benefit; therefore, shared decision-making is considered an essential component of effective LCS. The Centers for Medicare and Medicaid Services provides coverage for LCS following a mandated shared-decision making (SDM) visit. Here we review the concept of SDM, facilitators and barriers, evidence and knowledge gaps, and novel considerations for SDM within LCS. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2018        PMID: 30359617     DOI: 10.1016/j.chest.2018.10.013

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Evaluating Lung Cancer Screening Uptake, Outcomes, and Costs in the United States: Challenges With Existing Data and Recommendations for Improvement.

Authors:  Ashish Rai; V Paul Doria-Rose; Gerard A Silvestri; K Robin Yabroff
Journal:  J Natl Cancer Inst       Date:  2019-04-01       Impact factor: 13.506

Review 2.  Disparities in Lung Cancer Screening: A Review.

Authors:  Diane N Haddad; Kim L Sandler; Louise M Henderson; M Patricia Rivera; Melinda C Aldrich
Journal:  Ann Am Thorac Soc       Date:  2020-04

3.  Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment.

Authors:  Johannes F Fahrmann; Tracey Marsh; Ehsan Irajizad; Nikul Patel; Eunice Murage; Jody Vykoukal; Jennifer B Dennison; Kim-Anh Do; Edwin Ostrin; Margaret R Spitz; Stephen Lam; Sanjay Shete; Rafael Meza; Martin C Tammemägi; Ziding Feng; Samir M Hanash
Journal:  J Clin Oncol       Date:  2022-01-07       Impact factor: 44.544

Review 4.  The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countries.

Authors:  Eduardo Edelman Saul; Raquel B Guerra; Michelle Edelman Saul; Laercio Lopes da Silva; Gabriel F P Aleixo; Raquel M K Matuda; Gilberto Lopes
Journal:  Nat Cancer       Date:  2020-11-30

5.  Primary Care Physician Perceptions of Shared Decision Making in Lung Cancer Screening.

Authors:  Mohammad Abubaker-Sharif; Christine Shusted; Pamela Myers; Ronald Myers
Journal:  J Cancer Educ       Date:  2020-11-23       Impact factor: 1.771

6.  Impact of low-dose computed tomography for lung cancer screening on lung cancer surgical volume: The urgent need in health workforce education and training.

Authors:  Yi-Chi Hung; En-Kuei Tang; Yun-Ju Wu; Chen-Jung Chang; Fu-Zong Wu
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

Review 7.  Lung Cancer Screening: Review and 2021 Update.

Authors:  Anuradha Ramaswamy
Journal:  Curr Pulmonol Rep       Date:  2022-04-02

8.  What is the effect of a decision aid on knowledge, values and preferences for lung cancer screening? An online pre-post study.

Authors:  Stephen D Clark; Daniel S Reuland; Alison T Brenner; Michael P Pignone
Journal:  BMJ Open       Date:  2021-07-09       Impact factor: 2.692

9.  Factors influencing lung cancer screening completion following participation in shared decision-making: A retrospective study in a U.S. academic health system.

Authors:  Lior Rennert; Lu Zhang; Brandon Lumsden; Katon Harwood; Lauren Tyler; Morgan Ashby; Jeffrey W Hanna; Ronald W Gimbel
Journal:  Cancer Treat Res Commun       Date:  2020-07-17

10.  How Health-Care Organizations Implement Shared Decision-making When It Is Required for Reimbursement: The Case of Lung Cancer Screening.

Authors:  Amir Alishahi Tabriz; Christine Neslund-Dudas; Kea Turner; M Patricia Rivera; Daniel S Reuland; Jennifer Elston Lafata
Journal:  Chest       Date:  2020-08-13       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.